Table 2.
|
Clinical status |
Demographic |
Biochemical and virological |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
characteristics |
characteristics |
|||||||||
HCC (13) | ASC (24) | CR (33) | AH (7) | CH (4) | Male: Female | Age mean ±SD | ALT median IU/L (IQR) | HBeAg positive (%) | Viral loads log median IU/ml (IQR) | |
Genotype D (%) |
4(30.7) |
14(58.3) |
23(69.7) |
4(57.1) |
3(75) |
38:10 |
44.6 ±15.1 |
29 (19–57) |
4 (8.3) |
2.8 (2.0-3.9) |
Genotype E (%) |
6(46.2) |
6(25) |
8(24.3) |
3(42.9) |
1(25) |
17:07 |
49.3 ±14.3 |
29 (18–65) |
7 (29.2)a |
4 (2.6-5.7)a |
Genotype D/E (%) |
1(7.7) |
0 |
1(3) |
0 |
0 |
2:0 |
56.5 ±7.0 |
NA |
0 |
2.4 (2.3-2.41) |
Genotype A (%) | 2(15.4) | 4(16.7) | 1(3) | 0 | 0 | 5:2 | 38.14 ±14.51 | 33 (28–54) | 1 (14.3) | 2.6 (2.3-3.9) |
HCC, Hepatocellular carcinoma; ASC, Asymptomatic carriers; CR, Cirrhosis; AH, Acute hepatitis, CH, Chronic hepatitis.
aSignificant difference between patients infected with genotype D or E.